SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Inflazyme Pharmaceuticals (T.IZP) -- Ignore unavailable to you. Want to Upgrade?

To: Sean Janzen who wrote (1291)8/26/1999 10:17:00 AM
From: Sean Janzen  Respond to of 1501
 
Q2 results: biz.yahoo.com



To: Sean Janzen who wrote (1291)8/31/1999 3:17:00 PM
From: Luc Richard  Read Replies (1) | Respond to of 1501
 
What I can see from these stats is that if we go across the phase 2 of clinical trials, there is about 66 % of chance that we will to commercial phase, that is a very big prospect.

So we will have to wait up to that time for knowing if we have a good chance.

But I always think that the pre-clinical studies are very good and we will have success.

If I make some english spelling mistake, excuse me , I'm french ( from Quebec for sure ).

Thanks

Luc Richard


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News